Biotech · Private company
Saol Therapeutics Inc
Track this companyFree. Adds Saol Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Dichloroacetate (DCA)Phase 3 · Pyruvate Dehydrogenase Complex DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- GenotypePhase 3 · Pyruvate Dehydrogenase Complex DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- SL1002Phase 3 · Osteoarthritis Knee PainClinicalTrials.gov · fetched Nov 12, 2026
- SL-1002Phase 2 · Osteoarthritis, Knee PainClinicalTrials.gov · fetched Nov 12, 2026
- SL-1002Phase 2 · SpasticityClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee PainPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 7, 2025ClinicalTrials.gov NCT07226258 · fetched Nov 12, 2026
- Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee PainPHASE2 · UNKNOWN · started Jun 13, 2022ClinicalTrials.gov NCT05470608 · fetched Nov 12, 2026
- Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb SpasticityPHASE2 · UNKNOWN · started Apr 22, 2022ClinicalTrials.gov NCT05311215 · fetched Nov 12, 2026
- Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:PHASE3 · ACTIVE_NOT_RECRUITING · started Jul 14, 2020ClinicalTrials.gov NCT02616484 · fetched Nov 12, 2026